Publications by authors named "Zeliang Hu"

Triggering lysosome-regulated immunogenic cell death (ICD, e.g., pyroptosis and necroptosis) with nanomedicines is an emerging approach for turning an "immune-cold" tumor "hot"-a key challenge faced by cancer immunotherapies.

View Article and Find Full Text PDF

Aims: An applicable cerebral venous sinus thrombosis (CVST) model is imperative for exploring its pathophysiology. We established a novel severe CVST model using semi-ligation, ferric chloride, and thrombin.

Methods: A total of 138 male Sprague-Dawley rats were randomly divided into semi-ligation (n = 75) and non-semi-ligation (n = 63) groups.

View Article and Find Full Text PDF

Gliomas exhibit high intra-tumoral histological and molecular heterogeneity. Introducing stereotactic biopsy, we achieved a superior molecular analysis of glioma using O-(2-18F-fluoroethyl)-L-tyrosine (FET)-positron emission tomography (PET) and diffusion-weighted magnetic resonance imaging (DWI). Patients underwent simultaneous DWI and FET-PET scans.

View Article and Find Full Text PDF

Supratentorial extraventricular ependymomas (STEEs) are relatively rare ependymomas, and their pathologic and genetic characteristics are still poorly understood. The aim of this study was to determine the histologic, immunohistochemical, and RELA fusion features, as well as to clarify in more detail the clinical courses of STEEs. Data from a total of 43 patients with STEEs was analyzed retrospectively.

View Article and Find Full Text PDF

The histone H3 K27M mutation has been frequently reported in most diffuse midline gliomas. However, the relationship between the H3 K27M mutation and clinical outcomes of gliomas from different anatomical locations is still not fully understood. A total of 120 patients with diffuse midline gliomas were selected for this retrospective observational study.

View Article and Find Full Text PDF

Four bis-benzimidazolium salts, 1,4-bis[1'-(-R-benzimidazoliumyl)methyl]-2,3,5,6-tetramethylbenzene 2X ( : R = ethyl, X = PF; : R = picolyl, X = Br; : R = benzyl, X = Br; and : R = allyl, X = Br), and their three -heterocyclic carbene (NHC) Pd(II) and Ag(I) complexes, (), (), and (), as well as one anionic complex (), have been synthesized and characterized. Complex adopts a funnel-like type of structure, complex adopts a cyclic structure, and complex is an open structure. In the crystal packing of -, one-dimensional polymeric chains and two-dimensional supramolecular layers are formed via intermolecular weak interactions, including hydrogen bonds, π-π interactions, and C-H···π contacts.

View Article and Find Full Text PDF

MGMT promoter methylation is considered as a prognostic and predictive biomarker indicating response to chemotherapy and radiotherapy in glioblastoma. A number of different methods and platforms including pyrosequencing (PSQ), quantitative methylation-specific PCR (qMSP) and immunohistochemistry (IHC), methylation-sensitive high resolution melting (MS-HRM) and NGS (Next Generation Sequencing) have been used to detect MGMT promoter methylation in gliomas. However, controversy remains about the most appropriate method to use for analyzing MGMT status.

View Article and Find Full Text PDF

Bis-benzimidazolium salt (S)-2,2'-bis[2″-(N-Et-benzimidazoliumyl)ethoxy]-1,1'-binaphthyl hexafluorophosphate [(S)-LH]·(PF) and bis-imidazolium salts (S)-2,2'-bis[2″-(N-R-imidazoliumyl)ethoxy]-1,1'-binaphthyl hexafluorophosphate [(S)-LH]·(PF) and [(S)-LH]·(PF) (R = ethyl or benzyl), as well as their five N-heterocyclic carbene Hg(II) and Ag(I) complexes such as [(S)-LHg(HgBr)] (1), [(S)-LHg(HgBr)] (2), [(S)-LHg(HgI)] (3), {[(S)-LAg](PF)} (4) and [(S)-LAg](PF) (5) have been prepared and characterized. Each of complexes 1-3 consists of two rings (one 6-membered ring and one 11-membered ring), in which the oxygen atom in the ligand participates in coordination with Hg(II) ion. In complex 4, 1D helical polymeric chain is formed via biscarbene ligand (S)-L and Ag(I) ion.

View Article and Find Full Text PDF

Objective: To correlate the presence of chromosome 1p/19q deletion with the expression of R132H mutant IDH1 status in oligodendroglial tumors, and to explore molecular markers for predicting chemosensitivity of oligodendroglial tumors.

Methods: The study included 75 oligodendroglial tumors (38 oligodendrogliomas and 37 oligoastrocytomas). Immunohistochemistry was used to detect the expression of R132H mutant IDH1 protein, and fluorescence in situ hybridization (FISH) was employed to detect 1p/19q deletion.

View Article and Find Full Text PDF